Abstract:Motivation: Computational prediction of compound-protein interactions (CPIs) is of great importance for drug design and development, as genome-scale experimental validation of CPIs is not only time-consuming but also prohibitively expensive. With the availability of an increasing number of validated interactions, the performance of computational prediction approaches is severely impended by the lack of reliable negative CPI samples. A systematic method of screening reliable negative sample becomes critical to improving the performance of in silico prediction methods.Results: This article aims at building up a set of highly credible negative samples of CPIs via an in silico screening method. As most existing computational models assume that similar compounds are likely to interact with similar target proteins and achieve remarkable performance, it is rational to identify potential negative samples based on the converse negative proposition that the proteins dissimilar to every known/predicted target of a compound are not much likely to be targeted by the compound and vice versa. We integrated various resources, including chemical structures, chemical expression profiles and side effects of compounds, amino acid sequences, protein-protein interaction network and functional annotations of proteins, into a systematic screening framework. We first tested the screened negative samples on six classical classifiers, and all these classifiers achieved remarkably higher performance on our negative samples than on randomly generated negative samples for both human and Caenorhabditis elegans. We then verified the negative samples on three existing prediction models, including bipartite local model, Gaussian kernel profile and Bayesian matrix factorization, and found that the performances of these models are also significantly improved on the screened negative samples. Moreover, we validated the screened negative samples on a drug bioactivity dataset. Finally, we derived two sets of new interactions by training an support vector machine classifier on the positive interactions annotated in DrugBank and our screened negative interactions. The screened negative samples and the predicted interactions provide the research community with a useful resource for identifying new drug targets and a helpful supplement to the current curated compound-protein databases.

Computationally predicting protein-RNA interactions using only positive and unlabeled examples

Selecting high-quality negative samples for effectively predicting protein-RNA interactions

A Hybrid Prediction Method for Plant lncRNA-Protein Interaction.

Effectively Identifying Compound-Protein Interactions by Learning from Positive and Unlabeled Examples.

RPI-Pred: predicting ncRNA-protein interaction using sequence and structural information

PRIMITI: a computational approach for accurate prediction of miRNA-target mRNA interaction

RPIPCM: A deep network model for predicting lncRNA-protein interaction based on sequence feature encoding

Lasagna: Multifaceted Protein-Protein Interaction Prediction Based on Siamese Residual RCNN

Prediction of Pirnas Using Transposon Interaction and a Support Vector Machine

A convolutional network and attention mechanism-based approach to predict protein-RNA binding residues

De Novo Prediction of RNA-protein Interactions from Sequence Information.

IRWNRLPI: Integrating Random Walk and Neighborhood Regularized Logistic Matrix Factorization for lncRNA-Protein Interaction Prediction

Protein-Protein Interaction Prediction Model Based on ProtBert-BiGRU-Attention

Improving Compound-Protein Interaction Prediction by Building Up Highly Credible Negative Samples

Protein–protein interaction prediction based on ordinal regression and recurrent convolutional neural networks

HGNNPIP: A Hybrid Graph Neural Network framework for Protein-protein Interaction Prediction

PUTransGCN: identification of piRNA-disease associations based on attention encoding graph convolutional network and positive unlabelled learning

RNA-Protein Interaction Prediction Based on Deep Learning: A Comprehensive Survey

RPI-CapsuleGAN: Predicting RNA-protein interactions through an interpretable generative adversarial capsule network

Improving protein-protein interaction site prediction using deep residual neural network

A Transformer-Based Approach for the Prediction of the Effects of Missense Mutation on Protein–RNA Interactions